# A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

> **NCT03513939** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sernova Biotherapeutics Inc.** · enrollment: 17 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **COMBINATION_PRODUCT:** Sernova Cell Pouch

## Key facts

- **NCT ID:** NCT03513939
- **Lead sponsor:** Sernova Biotherapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-02-07
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2026-02-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03513939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03513939, "A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT03513939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*